Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR)

被引:98
作者
Chao, Elizabeth C. [1 ]
Velasquez, Jonathan L. [1 ]
Witherspoon, Mavee S. L. [1 ]
Rozek, Laura S. [2 ]
Peel, David [1 ]
Ng, Pauline [3 ]
Gruber, Stephen B. [2 ]
Watson, Patrice [4 ]
Rennert, Gad [5 ,6 ,7 ]
Anton-Culver, Hoda [1 ]
Lynch, Henry [4 ]
Lipkin, Steven M. [1 ]
机构
[1] Univ Calif Irvine, Canc Genet Clin, Div Hematol Oncol, Genet Epidemiol Res Inst, Irvine, CA 92697 USA
[2] Univ Michigan, Dept Internal Med Epidemiol & Human Genet, Ann Arbor, MI 48109 USA
[3] J Craig Venter Inst Human Genet, Rockville, MD USA
[4] Creighton Univ, Sch Med, Hereditary Canc Inst, Omaha, NE USA
[5] Carmel Hosp, Dept Community Med & Epidemiol, Haifa, Israel
[6] Techn Faculty Med, Haifa, Israel
[7] CHS Natl Canc Control Ctr, Haifa, Israel
关键词
Lynch syndrome; colorectal cancer; variants of uncertain significance; cancer genetics; HNPCC; MLH1; MSH;
D O I
10.1002/humu.20735
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Lynch syndrome, also known as hereditary nonpolyposis colon cancer (HNPCC), is the most common known genetic syndrome for colorectal cancer (CRC). MLH1/MSH2 mutations underlie approximately 90% of Lynch syndrome families. A total of 24% of these mutations are missense. Interpreting missense variation is extremely challenging. We have therefore developed multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR), a bioinformatic algorithm that effectively classifies MLH1/MSH2 deleterious and neutral missense variants. We compiled a large database (n>300) of MLH1/MSH2 missense variants with associated clinical and molecular characteristics. We divided this database into nonoverlapping training and validation sets and tested MAPP-MMR. MAPP-MMR significantly outperformed other missense variant classification algorithms (sensitivity, 94%; specificity, 96%; positive predictive value [PPV] 98%; negative predictive value [NPV], 89%), such as SIFT and PolyPhen. MAPP-MMR is an effective bioinformatic tool for missense variant interpretation that accurately distinguishes MLH1/MSH2 deleterious variants from neutral variants.
引用
收藏
页码:852 / 860
页数:9
相关论文
共 58 条
[31]   Predicting deleterious amino acid substitutions [J].
Ng, PC ;
Henikoff, S .
GENOME RESEARCH, 2001, 11 (05) :863-874
[32]   Accounting for human polymorphisms predicted to affect protein function [J].
Ng, PC ;
Henikoff, S .
GENOME RESEARCH, 2002, 12 (03) :436-446
[33]   Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer:: International Society for Gastrointestinal Hereditary Tumours Collaborative Study [J].
Park, Jae-Gahb ;
Kim, Duck-Woo ;
Hong, Chang Won ;
Nam, Byung-Ho ;
Shin, Young-Kyoung ;
Hong, Sung-Hye ;
Kim, Il-Jin ;
Lim, Seok-Byung ;
Aronson, Melyssa ;
Bisgaard, Marie Luise ;
Brown, Gregor J. ;
Burn, John ;
Chow, Elizabeth ;
Conrad, Peggy ;
Douglas, Fiona ;
Dunlop, Malcolm ;
Ford, James ;
Greenblatt, Marc S. ;
Heikki, Jarvinen ;
Heinimann, Karl ;
Lynch, Elly L. ;
Macrae, Finlay ;
McKinnon, Wendy C. ;
Moeeslein, Gabriela ;
Rossi, Benedito Mauro ;
Rozen, Paul ;
Schofield, Lyn ;
Vaccaro, Carlos ;
Vasen, Hans ;
Velthuizen, Mary ;
Viel, Alessandra ;
Wijnen, Juul .
CLINICAL CANCER RESEARCH, 2006, 12 (11) :3389-3393
[34]   Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases [J].
Peel, DJ ;
Ziogas, A ;
Fox, EA ;
Gildea, M ;
Laham, B ;
Clements, E ;
Kolodner, RD ;
Anton-Culver, H .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (18) :1517-1522
[35]   Mutations associated with HNPCC predisposition -: Update of ICG-HNPCC/INSiGHT mutation database [J].
Peltomäki, P ;
Vasen, H .
DISEASE MARKERS, 2004, 20 (4-5) :269-276
[36]   Classification of BRCA1 missense variants of unknown clinical significance [J].
Phelan, CM ;
Dapic, V ;
Tice, B ;
Favis, R ;
Kwan, E ;
Barany, F ;
Manoukian, S ;
Radice, P ;
van der Luijt, RB ;
van Nesselrooij, BPM ;
Chenevix-Trench, G ;
Caldes, T ;
de La Hoya, M ;
Lindquist, S ;
Tavtigian, SV ;
Goldgar, D ;
Borg, Å ;
Narod, SA ;
Monteiro, ANA .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (02) :138-146
[37]   Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer [J].
Piñol, V ;
Castells, A ;
Andreu, M ;
Castellví-Bel, S ;
Alenda, C ;
Llor, X ;
Xicola, RM ;
Rodríguez-Moranta, F ;
Payá, A ;
Jover, R ;
Bessa, X .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (16) :1986-1994
[38]   Statins and the risk of colorectal cancer [J].
Poynter, JN ;
Gruber, SB ;
Higgins, PDR ;
Almog, R ;
Bonner, JD ;
Rennert, HS ;
Low, M ;
Greenson, JK ;
Rennert, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (21) :2184-2192
[39]   Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1 [J].
Raevaara, TE ;
Korhonen, MK ;
Lohi, H ;
Hampel, H ;
Lynch, E ;
Lönnqvist, KE ;
Holinski-Feder, E ;
Sutter, C ;
McKinnon, W ;
Duraisamy, S ;
Gerdes, AM ;
Peltomäki, P ;
Kohonen-Corish, M ;
Mangold, E ;
Macrae, F ;
Greenblatt, M ;
de la Chapelle, A ;
Nyström, M .
GASTROENTEROLOGY, 2005, 129 (02) :537-549
[40]   Human non-synonymous SNPs: server and survey [J].
Ramensky, V ;
Bork, P ;
Sunyaev, S .
NUCLEIC ACIDS RESEARCH, 2002, 30 (17) :3894-3900